In the Limelight: Red Light Therapy Devices Compared, Kineon, PRUNGO & BioFlex

Kineon MOVE+ Pro vs PRUNGO FluxGo & Bioflex. A Scientific Comparison of Red Light Therapy Devices.

Red Light Therapy Comes of Age

Red light therapy (RLT), also known as photobiomodulation (PBM), has progressed well beyond the boundaries of experimental science. Today, it stands as a drug‑free, wearable solution for joint pain, inflammation, and recovery.

Photobiomodulation (PBM) is not simply the application of light to tissue; it is the precise orchestration of wavelength, coherence, and power density to trigger cellular repair. The distinction between laser-based PBM and LED-based PBM is not cosmetic; it is fundamental to efficacy.

The comparative evidence is clear: when LEDs are applied, their incoherent beams scatter broadly, distributing energy across the surface but failing to penetrate deeply. This diffusion produces warmth and superficial stimulation, yet the therapeutic signal dissipates before reaching the mitochondria, where true recovery begins. 

“PRUNGO’s so‑called power play relies on polarized light masquerading as a LASER, more spectacle than science, shining brightly against a wall but failing to penetrate where healing begins.”

In contrast, Class 1 LASERS deliver coherent, focused beams that concentrate energy at depth. The result is the targeted activation of inflamed or damaged tissue, resulting in measurable improvements in circulation, pain reduction, and functional recovery.

At the cellular level, the mechanism reinforces this distinction; Red and Near-Infrared photons in the 600–1000 nm range interact with two critical systems: Transient Receptor Potential Vanilloid ion channels.  TRPV ion channels and the mitochondrial respiratory chain. Coherent laser light reliably activates cytochrome c oxidase, enhancing electron transport and ATP synthesis.

The principal ion channels you will see in the schematic diagram below are the TRPV1 ion channels, solely involved in the perception of heat and pain sensations, from sources like capsaicin, heat, and protons. As they are sensitive to heat, Red and Near Infrared NIR light produces localized photothermal effects that raise tissue temperature enough to activate the channel.

This is also why the science around Photobiomodulation and the Arndt-Schulz Biphasic dose response curve requires a precise, tailored, and well-researched approach, not just an espresso shot that douses the ion channels and overwhelms them rather than activating them correctly, as we see with the "Prungo Power Play".

You can see this in the infographic pathway below, adapted from a study conducted by Nairuz L et al., 2024, from their Cells Journal publication on the effects of Photobiomodulation Therapy on the Brain; a study that investigated the use of Red Light Therapy delivery to the brain, as an alternative approach to 'revolutionize Cognitive Dynamics'.

Read further to grasp the concepts of Photobiomodulation and let the truth speak for itself in the world of Red Light therapy.

A Note on Comparison Blogs

Many comparison articles circulating online recycle manufacturer specs without validating irradiance, beam profile, or dose delivery. Some even reuse identical templates across multiple devices, creating the illusion of analysis while offering little more than rearranged marketing claims.
This guide takes a different approach.
•     Specs are cross‑checked against manufacturer documentation
•     Claims are evaluated through the lens of PBM science
•     No affiliate incentives influence conclusions
•     Every distinction is tied back to mechanism, dose, and tissue response
In a landscape where superficial comparisons can mislead readers, this article prioritizes clinical clarity, scientific accuracy, and real‑world therapeutic relevance.

A Note on Skin‑Depth Science and Facial Applications

Most device comparisons stop at surface‑level metrics, wavelength, power, and marketing claims, without addressing how light actually behaves once it enters biological tissue. True photobiomodulation is depth‑dependent: different chromophores, ion channels, and mitochondrial complexes respond at different layers of the skin.

This is why understanding skin‑depth penetration matters! 

Pun Intended! We Really Use The Kineon as a revolutionary skin anti-aging and glow-up mask!

Red light (around 630–660 nm) interacts primarily with the epidermis and superficial dermis, influencing collagen synthesis, fibroblast activity, and microcirculation. Near‑infrared light (810–850 nm) penetrates deeper, reaching the subdermal layers where inflammation, muscle tension, and joint structures reside.

Because of this layered response, devices engineered for joint recovery can, when designed with modular, targeted emitters, also deliver meaningful benefits to the skin.
This is where the Kineon Move+ stands apart.

Its individual pods are not just “attachments”; they are independent, high‑irradiance PBM modules capable of delivering concentrated red and near‑infrared light to small, anatomically specific areas. When used on the face, a single pod can function as a precision facial PBM tool, supporting:

•     Localized collagen stimulation
•     Improved microvascular flow
•     Reduced inflammation in targeted zones
•     Enhanced mitochondrial activity in fibroblasts

This is not a marketing claim; it is a direct consequence of coherent dose delivery, wavelength pairing, and the physics of tissue penetration.

While the Move+ is not marketed as a beauty device, its modular architecture gives it a versatility that superficial LED masks cannot replicate. Where masks diffuse energy broadly, the Move+ pods deliver focused, therapeutic‑grade light to the exact depth where fibroblasts and dermal mitochondria respond. We view it as a versatile and highly decisive targeted Red Light and Class 1 Laser. 

How does Red and near-infrared light actually work at a cellular level, & Why do I need it?

This cascade generates secondary messengers, nitric oxide, reactive oxygen species, and cAMP, which initiate retrograde signaling to the nucleus. Transcription factors such as NF-κB and AP1 are then engaged, driving gene expression that reduces inflammation and accelerates tissue repair. Without sufficient coherence and penetration, LEDs struggle to trigger this full cascade, leaving their effects partial and inconsistent.

The MOVE+ Pro embodies this scientific advantage by harnessing Class 1 LASERS; it achieves safe, clinically relevant penetration while remaining accessible for home use.

Unlike higher-class lasers that require supervision, Class 1 systems balance safety with efficacy, ensuring that users experience both immediate relief and long-term cellular benefits. This dual impact, surface-level comfort and deep mitochondrial activation, positions MOVE+ Pro as the gold standard in at-home PBM.

"This isn’t just light, it’s precision medicine disguised as everyday recovery. Where LEDs scatter, lasers focus. Where others warm, MOVE+ Pro heals."

Think of PBM as solar panels for your cells: light is captured by mitochondria, the body’s natural power plants, to generate energy that fuels repair and renewal. While many devices crowd the marketplace, only a select few are engineered with true clinical depth and efficacy.

Red and near‑infrared wavelengths work in tandem:

• Red light (~660 nm): Supports surface‑level repair, skin rejuvenation, and inflammation reduction, such as Theraface Mask and Theraface Glo, with which we are in partnership with Therabody USA. 
• Near‑infrared (~808–850 nm): Penetrates deeper tissues, stimulating muscles, tendons, and joints for regeneration. Here we delve into the specifications and clinical efficacy of Kineon's MOVE+Pro LASER over Prungo and BioFlex home delivery Red and NIR devices.

 

Red and near‑infrared wavelengths work in tandem: red light supports surface‑level repair, while infrared penetrates deeper tissues to drive regeneration. This dual action is supported by more than 10,000 peer‑reviewed studies, establishing PBM as one of the most researched non‑invasive therapies available.

The Science of Optimal Dosing and MOVE+ Pro’s Mechanism of Action

Red light therapy works by stimulating blood flow and cellular energy production (ATP) in targeted tissues. This cascade reduces pain and inflammation while triggering repair processes that help damaged cells recover.

The therapeutic response observed with MOVE+ Pro follows the classic Arndt‑Schulz Biphasic Dose Curve, a bell‑shaped relationship between dose and effect. Within the optimal range of intensity and duration, light exposure produces the most significant benefits. Too little stimulation fails to activate cellular pathways, while excessive exposure can diminish outcomes or even provoke adverse effects.

Later in this discussion, we’ll take a deeper dive into the energy dynamics and efficiency of photobiomodulation, highlighting which devices truly embody its clinical principles and which fall short, offering little more than a placebo effect against the basic yardsticks of scientific expectation.

MOVE+ Pro solves this challenge with three preset modes, calibrated to the “golden” wavelengths of 660 nm, 808 nm, and 850 nm. These ranges are clinically validated to activate tissue photoreceptors, ensuring consistent recovery across diverse users, from athletes to everyday individuals seeking mobility and resilience.

At the physiological level, MOVE+ Pro’s Class 1 lasers initiate three potent actions:

•Targeting inflammatory mediators through precise wavelength delivery, reducing cytokine activity.
•Driving nitric oxide release into plasma, widening vessel diameters in a titrated, safe response that boosts circulation without interfering with cardiovascular medications.
•Stimulating angiogenesis, the formation of new capillaries at damaged sites, accelerating tissue repair by up to 36% in trials.

We will revisit this in a more technically focused, energy‑driven review to ensure the mechanism is fully clarified, leaving no loose ends and eliminating any guesswork.

This multidimensional model improves oxygen tension in chronically inflamed tissues, enhances ATP production, and reduces oxidative stress at its root cause. The result is not only pain relief and mobility restoration but also systemic benefits: healthier vascular function, improved energy metabolism, and even skin rejuvenation through collagen synthesis and enhanced microcirculation.

With recommended use, two or more sessions per week, gradually increasing exposure, users can sustain the peak of the biphasic curve, maximizing photoreceptor activation and long‑term outcomes. MOVE+ Pro transforms red light therapy into a precision‑engineered, clinically grounded solution for recovery, rehabilitation, and radiant longevity. 

Once considered fringe, PBM is now widely adopted in clinical practice, helping patients and athletes alike move from debilitating conditions toward restored mobility and sustained recovery.

“Beauty That’s More Than Skin Deep”

The same mitochondrial cascade that accelerates joint repair also rewires the biology of skin. When Class 1 lasers penetrate deeply enough to activate fibroblasts, they stimulate the production of collagen and elastin, the scaffolding that supports youthful resilience.

 Nitric oxide enhances microcirculation, delivering oxygen and nutrients for a healthier appearance, while modulating the NF-κB and AP-1 pathways, which reduce oxidative stress, one of the primary drivers of premature aging.

 Unlike LEDs, which scatter light and provide only surface warmth, coherent laser light reaches the cellular targets that matter, halting aging where it begins: in the mitochondria. For skincare enthusiasts, this means MOVE+ Pro is not just recovery technology; it is a science‑backed path to radiant longevity.

      Caption: Kineon MOVE+Pro Class 1 Laser device with the new modified strap system,              available for purchase on Rivete Advanced Recovery & Mobility.

Not All Devices Are the Same

When comparing red light therapy devices, the real distinction lies not in how bright they appear or how much power they claim to deliver, but how precisely they adhere to the therapeutic window defined by the Arndt‑Schulz biphasic law. 

The Kineon MOVE+ Pro is engineered with medical‑grade laser diodes, calibrated to deliver dosing that remains squarely within this healing zone. Its design reflects a commitment to precision, ensuring that every photon contributes to cellular repair rather than risking suppression or inhibition completely.

In contrast, the PRUNGO FluxGo leans heavily on raw intensity. Its marketing emphasizes being “powerful,” but intensity without calibration is a gamble. Overshooting the narrow therapeutic window risks undermining recovery, turning what should be a healing stimulus into an inhibitory overload.

The BioFlex Nano and 360 Bundle occupy yet another position in this landscape. These devices are consumer‑grade adaptations of Bio Flex's professional systems, built on the same underlying science of photobiomodulation but relying exclusively on LEDs.

Their design prioritizes coverage over precision, bathing larger areas in diffuse light but lacking the coherent, laser‑anchored dosing that ensures deep penetration and calibrated delivery.

At Rivete Advanced Recovery & Mobility, a trusted partner in the Shopify Collective network, and in collaboration with our brand partner Kineon, we believe it is essential to set the record straight. The following sections examine the specifications and claims of PRUNGO alongside Bio Flex's consumer devices, showing how both diverge from the calibrated dosing discipline that defines the Kineon MOVE+ Pro.

For this review, we’re focusing on products that mimic much of the Kineon MOVE+ Pro’s design and claims, yet omit its defining feature: the integration of medical‑grade lasers. In other words, they borrow the look and language of photobiomodulation, but stop short of delivering the calibrated, coherent dosing that sets Kineon apart.

Why Kineon Became a Breakthrough & Set Industry Standards? 

Launched in fall 2021, the MOVE+ Pro marked a breakthrough in drug‑free pain relief that are home-use devices, bringing physiologically optimized recovery out of the clinical lab and directly into your hands.

Unlike static light panels or generalized spa devices, the MOVE+ Pro applies targeted photobiomodulation in a compact, wearable form. By combining dual therapeutic wavelengths (red and near-infrared) with laser-anchored dosing, it ensures precise photon delivery to tissue with surgical precision and vector delivery directly into target tissues.

This design enhances mitochondrial activation, circulation, and cellular repair, offering recovery that is both clinically rigorous and conveniently accessible. 

MOVE+ Pro pods emit dual wavelengths of red and infrared light, targeting joints with precision and depth. This close-up reveals the active light arrays that drive cellular repair, reduce inflammation, and restore mobility, all without heat buildup or energy loss.

Description
This close-up image of our 2nd personal unit captures the Kineon MOVE+ Pro pods in active mode, showcasing the vibrant red and infrared LED arrays. Each pod features a precision-engineered cluster of light sources arranged for optimal coverage and penetration.

The intense red glow and diffused halos illustrate the dual-wavelength output at 660 nm red LEDs for surface stimulation and 808 nm infrared lasers for deeper tissue activation. The visual symmetry and brightness reflect the device’s ergonomic design and calibrated energy delivery, key to its therapeutic precision.

Portable, Wireless & Clinically Precise

Kineon MOVE+ Pro is a wireless, non‑pharmaceutical, USB‑C rechargeable red light therapy device.

Each unit docks magnetically into a compact charging case, combining portability, precision, and clinical‑grade efficacy in one modular system, complete with adjustable straps and extension straps, some of which are sold separately, but most of which come in your packaged order. 

New extension straps, sold separately, were designed to improve length and usability after some users found the original system confusing.

Image: This is our second Kineon MOVE+ Pro unit, featuring three modular pods with 8 × 660nm red LEDs and 10 × 808nm infrared laser diodes per pod. Designed for precise, wearable photobiomodulation that targets both surface and deep tissue repair. Pictured above are the 3 pods in their recharging dock in the chargeable carrying case, Kineon MOVE+Pro Class 1 Medical LASER and NIR Photobiomodulation.

Each unit contains three modular therapy pods, engineered with dual emission zones for comprehensive recovery. Within every pod are 8 × 660nm deep red LEDs that stimulate surface‑level regeneration, paired with 10 × 808nm infrared laser diodes designed for deep tissue repair.

Image: Close-up of our second Kineon MOVE+ Pro unit, showcasing the hexagonal LED clusters housed in soft silicone pods. Each pod delivers dual-wavelength photobiomodulation, featuring 8 × 660nm red LEDs for surface-level repair and 10 × 808nm infrared laser diodes for deep tissue recovery, engineered for calibrated, wearable healing that travels with you.

This dual‑wavelength configuration ensures the MOVE+ Pro delivers both superficial and penetrating photobiomodulation, calibrated to remain inside the therapeutic healing window defined by the Arndt‑Schulz biphasic curve. The result is precise, medical‑grade dosing that maximizes mitochondrial activation, ATP synthesis, and tissue recovery without overshoot.

It delivers a layered therapeutic response, relieving pain, improving mobility, and enhancing physical performance both in daily life and athletic recovery.

 For individuals who use wheelchairs, the MOVE+ Pro offers a unique advantage: its modular pods contour naturally to joints and muscles even in seated positions, making consistent therapy accessible without the need for complex repositioning, and better yet, you can use it without any backrest or seating impediments; it's a strap system and will not interfere with your seating arrangement or comfort.

Everyday Recovery

This means improved circulation, reduced inflammation, and faster rehabilitation for areas that often endure chronic strain, such as shoulders, hips, and knees. From post‑surgical healing to long‑term recovery, its calibrated dosing and ergonomic design support a wide spectrum of needs. The same close skin contact and anatomical conformity that benefit human users have even been applied successfully to injured pets, underscoring the device’s versatility across different recovery contexts.

🐾 Beyond Humans

Beyond human recovery, the MOVE+ Pro has also been successfully used with injured pets. Its close skin contact and ergonomic design allow the therapy pods to conform naturally to anatomical curves, whether that’s a knee joint or the rounded contours of a paw or hip.

For example, a pug recovering from joint strain or hip and mobility impairments can benefit from the same dual-wavelength photobiomodulation that supports human healing, utilizing red LEDs for surface repair and infrared lasers for deeper tissue recovery.

This versatility underscores the device’s gentle, non‑invasive nature, making it a trusted companion for rehabilitation across species. It can also pepper them into rehabilitative movement and take steps in the right direction to lead healthier, more fulfilling pet lives, by virtue of the same mechanisms that operate in humans.

The 808 nm Class 1 lasers deliver 50 mW per module, while the red LEDs emit 80 mW per zone, all calibrated to stay within the Arndt‑Schulz therapeutic window for safe, effective healing. 

It finds itself in other areas of application for your beloved fur babies and children, yes, it's universal applicability and safe therapeutic margins, without overshooting the beneficial window, ensuring you can use it at any age and for pets too!

Here at Rivete, we are ardent pug lovers, and recommend one for your pug's mobility or rehabilitation, also designed to fit like a harness, have them rested, and it's got an auto timer to switch off when the cycle completes.

What are Class 1 Lasers? 

Class 1 lasers are the safest category of laser products under international (IEC) and US (FDA) standards. They are engineered so that normal use poses no risk of eye or skin damage, making them suitable for general consumer applications without the need for protective eyewear.

To understand why the MOVE+ Pro is both safe and effective, we need to examine the hierarchy of laser classifications. International (IEC) and US (FDA) standards divide lasers into categories based on their potential risk to the eyes and skin. At the safest end of the spectrum sits Class 1.

The deduction is simple: if a laser is engineered so that normal use cannot produce harmful radiation levels, then it poses no hazard. Class 1 devices achieve this by limiting accessible emission or enclosing higher‑class lasers within protective housing. Everyday technologies such as CD/DVD players and laser printers rely on this principle; powerful lasers may be inside, but the user never encounters unsafe exposure.

Applied to photobiomodulation, the Kineon MOVE+ Pro integrates LEDs with infrared Class 1 lasers to deliver targeted therapy. Each module contains ten infrared diodes at 5 mW each (50 mW total), yet the accessible emission remains safely within Class 1 limits. The logical conclusion: the device can be used in direct skin contact for long‑term therapy without protective eyewear, even by individuals with vision impairments or cataracts, provided they avoid prolonged staring into the light.

Think of the difference as a floodlight versus a spotlight. Panels scatter energy broadly, often wasting or diffusing light. The MOVE+ Pro, by contrast, directs calibrated beams exactly where the body needs them, combining clinical rigor with everyday safety.

Image/chart: (Comparison chart: MOVE+ Pro vs higher‑class lasers such as Class 3 and 4, can be inserted here for visual clarity.)

 

Beyond Class 1: Why Safety Matters?

Once we move beyond Class 1, the reasoning shifts. Class 3B lasers deliver higher power outputs capable of penetrating deeply into tissue, but they also introduce risk. Direct exposure can damage the eyes, which is why these devices are confined to clinical settings under professional supervision.

Bio Flex's Professional systems exemplify this category: they combine Class 3B lasers with LED arrays to achieve powerful therapeutic dosing, but they require trained operators, protective eyewear, and strict protocols. The margin for error is narrow; precision and control are essential.

At the far end of the spectrum are Class 4 lasers, powerful enough to cut or burn tissue. These are reserved for surgical procedures, industrial applications, and advanced physiotherapy clinics. While they can deliver dramatic therapeutic effects, they also carry significant risks: accidental exposure can cause permanent eye injury or skin burns. Class 4 devices demand rigorous safety measures, controlled environments, and specialized training.

By deduction, the MOVE+ Pro’s reliance on Class 1 lasers is not a compromise but a deliberate design choice. It ensures that calibrated photobiomodulation can be delivered safely in everyday settings, at home, in the gym, or even for wheelchair users and pets, without the hazards associated with higher‑class lasers and the price tag, which requires only trained personnel to deliver treatments or customize them for you.

The reasoning is clear: Class 3B and Class 4 lasers may offer raw power, but they require supervision and safety gear. Class 1, when engineered with precision as in the MOVE+ Pro, achieves the therapeutic window without risk, bridging clinical science with consumer usability.

“Kineon MOVE+ Pro: Proof That Class 1 Lasers Deliver Power Without Risk”

Precision vs Power in Red Light Therapy

Why Dosing Accuracy Matters?

Prungo’s pods may flaunt raw wattage in a modular strap system, but without calibrated dosing, they overshoot the therapeutic window and rely solely on LEDs. According to the 3D Thor model of the Arndt‑Schulz biphasic curve, a shock dose of 216 J/cm² is far beyond the optimal range.

Rather than enhancing recovery, such excessive energy risks suppressing tissue response altogether. What remains is a placebo illusion, the assumption that more power equals more impact, when in reality, physics dictates that precision, not brute force, drives favourable outcomes.

Kineon’s MOVE+ Pro, in contrast, harnesses 808 nm infrared laser diodes engineered for precision. Its dosing is tuned to 36 J/cm² in 15 minutes, landing squarely in the biphasic healing zone where mitochondrial activation and ATP synthesis peak. The result is repeatable, science‑anchored repair, that's not scattered intensity. Prungo flaunts power; MOVE+ Pro delivers precision, depth, and clinically proven outcomes.

Prungo claims superior module design, but most of that promise is lost in a wall‑of‑power display. The capsular layout bleeds energy outward, allowing light to slip and scatter into the surroundings instead of concentrating at depth.

In physics, a system that hemorrhages energy to the environment or requires extraordinarily high loading doses only to taper off sharply is inherently inefficient. It’s spectacle without substance, wattage wasted rather than healing delivered.

It doesn't matter whether light scatters on walls, is lost to its surroundings, or plays a game of shadow puppetry when the foundations of photobiomodulation are lost to mere spectacle. In the case of Prungo's delivery and science, its polarized LED is dressed up as a polarized Laser, without the actual laser.

Kineon wins because it respects science, is engineered for bio-effective regeneration and reparative power, rather than spectacle.

To frame the discussion ahead, we begin with the Arndt‑Schulz biphasic curve and then move into deeper planes to uncover the core scientific principle behind Kineon’s MOVE+ Pro Class 1 home‑use laser device. This principle will be referenced throughout the guide as the anchor for understanding dosing accuracy and therapeutic outcomes.

This review has been authored by Rivete Advanced Recovery & Mobility, and may be shared or cited as we have cited the pioneering researchers who established and advanced this science.

What Is the Arndt-Schulz Principle?

In the late 1800s, pharmacologist Hugo Schulz and psychiatrist Rudolf Arndt discovered a paradox, and it opened the floodgates to light irradiation as a clinical regenerative and recovery modality.

The principle behind the Arndt‑Schulz law dates back to the late 1800s, when pharmacologist Hugo Schulz and psychiatrist Rudolf Arndt observed that low doses of certain agents could stimulate biological activity, while higher doses suppressed it. This paradox, later termed hormesis, shows that living systems thrive on calibrated stimulation rather than brute force.

The Arndt‑Schulz Curve Explained 

We have laid some pretty impressive foundations already, but we're ready to take a nose-dive into what this revolutionary principle has in store for you and your biohacking recovery & regenerative journey. Below, we'd like to think of stimuli, whether it be light or substances, or doing too much of something, in terms of a cup of joe.

We're also going to look at a competing philosophy, the Bunsen-Roscoe Principle of Light irradiation, with respect to the devices we've brought into this discussion earlier.

Defining The Arndt-Schulz Principle

Low doses stimulate biological activity, whilst High doses suppress it. This principle, later called hormesis, shows that living systems thrive on calibrated stimulation, not brute force. The tipping point where it spills over and is either too much or doesn't live up to the hype is what we ought to steer away from if we want to talk photobiomodulation.

In modern low‑level light therapy (LLLT), the same rule applies. Irradiation time and intensity follow a biphasic curve: too little light yields no effect, the right dose stimulates healing, and too much suppresses it. 

This nonlinear response contradicts the old Bunsen‑Roscoe reciprocity rule, proving that energy density alone doesn’t predict outcomes.

Devices like the Kineon MOVE+ Pro embody this lesson, delivering dual wavelengths within the therapeutic window, while “more power” approaches risk overshooting and undermining recovery.

Think of light therapy for pain relief and joint recovery like your morning coffee: We've mentioned it above, but here we will dive in a little deeper and get into the science of irradiation and light therapy.

•Too little caffeine = no effect
•Just enough = alert, focused, ready to go
• Too much = jittery, anxious, crashing by noon

Cells respond to light in the same way. The Arndt‑Schulz biphasic dose‑response curve defines the “Therapeutic Window” between 10–70 J/cm².

•Below that → nothing happens
•Above that → healing slows, or recovery is sabotaged. Kineon MOVE+ Pro lands squarely in this window, engineered for bioeffective regeneration and reparative power.

 The Arndt-Schulz Biphasic Dose-Response Curve

This curve is the scientific baseline for photobiomodulation therapy.

Caption:
3D Dose-Response Model for Photobiomodulation (PBM). This visual compares the traditional 2D dose-response curve with a 3D model that incorporates both irradiance and time. Developed by James D. Carroll, the THOR 3D model illustrates how varying combinations of dose and exposure duration influence biological outcomes, from stimulation to inhibition. It underscores the importance of calibrated dosing in LED and low-level laser therapy.

Citation:
Carroll, J.D. (2008). A 3D dose model for low-level laser / LED therapy biostimulation and bioinhibition*. THOR Photomedicine Ltd. Published 12 February 2008. Licensed under Creative Commons Attribution-ShareAlike 4.0 Unported (CC BY-SA 4.0). Source: [THOR Photomedicine](http://blog.thorlaser.com/3D)

Let's break that down for you.

“The dose‑response curve tells the story: Kineon’s Class 1 pods hit the safe stimulation zone, PRUNGO and BioFlex Nano/360 scatter LEDs with less precision, while BioFlex pro Class 3B and Class 4 lasers demand supervision. Precision matters, and Kineon delivers it safely at home.”

The Arndt‑Schulz biphasic dose‑response curve establishes that low doses of photonic energy stimulate cellular activity, while excessive doses suppress or inhibit biological function. 

The biphasic curve is a bell curve that is an 'inverted U' curve, with the X axis (horizontal line) representing the dose of red light, or infrared light. It represents Irradiance in terms of Watts per square centimetre of tissue exposed, from the above graph. 

The Y axis, or long axis, of the graph above represents your body's tissue response, or biological response to this stimulus, in terms of resolution of pain, onset of healing measured symptomatically or objectively, and better blood flow or improved energy levels. 

The peak of the bell curve lies at the "optimal dose" that elicits the most significant therapeutic effects, and understanding it becomes crucial when you invest in your device. It is important to realize that too low an exposure is ineffective and wasteful expenditure, or too high and powerful, like Prungo, then you've significantly overshot the window of clinical efficacy.

This principle is foundational in photobiomodulation (PBMT) because mitochondria and their photoreceptors (notably cytochrome c oxidase) respond non‑linearly to light exposure. Precision in irradiance (mW/cm²), fluence (J/cm²), and exposure time is therefore critical to remain within the therapeutic window. These are your metrics for establishing how efficacious your home use of the Red Light Therapy Device is. 

Think of your cells like little batteries. If you give them just the right amount of light, they charge up and work better. Too little light and nothing happens; too much light and the battery gets overloaded and shuts down, think of burnout and exhaustion from doing more than you can handle at any given time. This is where the Kineon MOVE+ Pro is ideally positioned, with your best life as the priority for its design.

That’s why the right balance of power, time, and dose matters; it’s the difference between real healing and wasted energy. These are the simple yardsticks that tell you if a red light therapy device is actually helping your body or just shining bright for show.

 

 

“Prungo Gambles, BioFlex Falters, MOVE+ Pro Delivers”

At first glance, the PRUNGO Flux Go and the BioFlex Nano look familiar, from packaging to website, much feels borrowed. Beneath the surface, however, the differences are critical.

PRUNGO leans heavily on claims of raw power, showcasing videos of blinding intensity, but this emphasis on wattage risks sidelining the science that truly drives healing. By chasing intensity and claims of "Power", instead of calibrated dosing, PRUNGO gambles against the very foundation of Photobiomodulation, PBM.

While BioFlex Nano 360 and its BioFlex Wave, using the individual pods in an adjustable strap system, identical to Kineon and Prungo, present themselves as a sleek, wrap‑around solution for red light therapy. 

Their design prioritizes coverage over precision, and the pods rely solely on LEDs, no medical‑grade lasers, which means light scatter is high and penetration depth is limited.

Its design lacks anatomical conformity, as it sits flat, and there is a lot of circumferential energy loss to the environment rather than being beneficially absorbed. In Physics, loss to the environment is a waste, and often such systems are deemed inefficient.

This makes it suitable for surface-level wellness but less effective for deep tissue recovery.
The flat pod structure struggles to contour around curved joints like knees or shoulders, leading to uneven irradiance and patchy dose delivery, and worst still, a lot is lost to the surroundings.

The same could be said of Prungo's capsular module that emits peripheral red light, as they show in their claims of being a 'powerful' module, except it's against a wall. The capsular design lets light escape without a focused "surgical arrow" like Kineon's Move+ Pro with LASER.

Measuring this is challenging across any at‑home red light device, but the baseline remains clear: effective technology must adhere to the established laws of photobiomodulation and efficiency. In practice, that means designing devices that complement the physical principles on which they are founded, rather than relying on intensity alone.

And while either the Prungo or BioFlex Wave and nano pod devices offer multiple therapy modes, they lack calibrated dosing aligned with the Arndt‑Schulz principle, meaning sessions may be safe, but not necessarily therapeutic.

It's Not The Bioflex you think it is!

BIOFLEX positions itself as a leader in photobiomodulation by combining Class 3B lasers with large LED arrays, emphasizing polarization and systemic blood irradiation. Yet under the lens of the Arndt‑Schulz law, this approach falters.

The biphasic dose‑response curve makes clear that mitochondrial activation is non‑linear: too little light fails to stimulate, too much suppresses function. BIO Flex's reliance on broad LED scatter and higher power dosing risks overshooting into the suppression zone, producing thermal inhibition rather than repair.

Kineon’s MOVE+ Pro, in contrast, is engineered around calibrated Class 1 infrared lasers at 808 nm, a wavelength identified by Tina Karu as optimal for cytochrome c oxidase absorption and deep musculoskeletal penetration.

 Each module combines 10 infrared diodes (5 mW each) with 8 deep‑red LEDs, delivering athermic stimulation that is safe for home use yet clinically effective. Its dosing is precise: 36 J/cm² in 15 minutes, staying squarely within the biphasic therapeutic window.

Unlike systems that scatter power inefficiently, MOVE+ Pro channels light coherently and ergonomically to joints, ensuring repeatable mitochondrial activation and tissue repair.

Where BIOFLEX confuses volume with efficacy, Kineon adheres to the biphasic discipline, ensuring targeted mitochondrial activation, cumulative ATP synthesis, and genuine tissue regeneration.

In short, BIOFLEX’s polarization narrative masks an intensity‑first model, while Kineon’s MOVE+ Pro embodies the science of photobiomodulation: healing at the peak, not suppressing in the trough.

The BioFlex Nano 360 is designed for gentle, routine use, not clinical-grade recovery. It’s a lifestyle device, not a precision tool. 

BIOFLEX’s LED‑dominant, polarization‑focused model prioritizes volume and systemic exposure but lacks the calibrated precision required by the Arndt‑Schulz law. This risks suppression, thermal inhibition, and inconsistent dosing.

Kineon MOVE+ Pro, by contrast, delivers laser‑anchored, biphasic‑calibrated dosing, coherent beams at 808 nm, precise fluence delivery, and ergonomic targeting. It adheres to the photobiomodulation principles established by Karu and the biphasic dose‑response curve, ensuring mitochondrial stimulation without overshoot.

Caption: In a Nutshell, the technical and dosing principles of the BioFlex Nano, its 360 bundle, and more clinically designed devices like BioFlex Wave all rely on the same fundamental policy of photobiomodulation, nowhere close to the precise delivery of Kineon MOVE+Pro as mentioned above.

 

Prungo's Polarization Mirage

PRUNGO’s “Polarized Laser Therapy” is a textbook case of marketing inflation. The device is powered almost entirely by dense LED arrays, yet PRUNGO sprinkles in a few weak Class 3R laser diodes, adds a polarized filter, and rebrands the whole thing as a laser‑based breakthrough.

As we sift through older comparison pages, a pattern becomes impossible to ignore: an almost frantic effort to overshadow the Kineon MOVE+ Pro with repetitive content. Many of these posts recycle the same headlines with wildly inconsistent claims, and the deeper you read, the clearer it becomes that it’s less about informing the reader and more about forcing a narrative.

The message they keep pushing is simple: “more is better,” as if stacking features automatically brings you closer to your recovery goals. But when you look past the noise, the strategy feels more like a power play than genuine guidance.

These consumer‑grade lasers contribute no meaningful photobiomodulation effect; they simply provide a convenient excuse to use the word “laser.” In reality, PRUNGO functions as an LED device dressed up in optics jargon to appear more clinical than it is.

In reality, the mechanism remains intensity‑driven: more light, more power, more risk. Polarization may reduce scatter, but it does not change the fundamental dosing model. Without calibrated biphasic discipline, the therapy risks overshooting the therapeutic window and suppressing rather than healing.

The contrast with Kineon is stark. Kineon’s MOVE+ Pro is built on the Arndt‑Schulz biphasic principle, delivering precise, measured doses that stay within the healing window and actually deliver on the promise they make to you.

PRUNGO borrows the authority of medical optics but fails to deliver calibrated outcomes, while Kineon’s approach is grounded in clinical evidence and cumulative tissue repair.

In short, PRUNGO confuses optics with efficacy and fancy wordplay, whilst Kineon heals smarter, not louder, proving that precision, not polarization, is what drives recovery, and with medical-grade LASERS worth their weight in gold. Excessive power displays and flashing lights are an example of waste, especially if it's powerful on a wall but flaunts only Polarization Mirage. 

Why Kineon Stands Apart?

The Kineon MOVE+ Pro is built around precision 808 nm Class 1 infrared lasers and 660 nm deep red LEDs, delivering targeted energy that stays within the therapeutic window rather than wasting power in scatter. Unlike competitors such as Prungo or Bioflex, which rely heavily on LED‑only designs or wattage‑first claims, the MOVE+ Pro combines calibrated laser and LED technology for deeper penetration (up to 5–6 cm vs. ~2 cm for standard panels) and genuine mitochondrial activation.

Key Advantages of the MOVE+ Pro

• Dual Laser + LED Therapy: Comprehensive coverage of both surface tissue and deeper musculoskeletal layers.
• Targeted, Joint‑Specific Design: Modular, strap‑based system ensures pinpoint dosing for knees, shoulders, and elbows, and areas where flat panels lose efficiency or cannot intimately contact for the deepest levels of clinical efficacy.
•Safe Class 1 Lasers: Engineered for consumer safety (no eye protection required) while maintaining clinical efficacy.
•Portable & Hands‑Free: Battery‑powered, Bluetooth‑linked modules allow therapy during daily activities in 5–15 minutes.
•Ease of Use: Magnetic charging, one‑button activation, and no gels or complex setups.
•Trusted Endorsements: Backed by athletes, therapists, and chronic pain users reporting reduced pain, inflammation, and stiffness.
•Cost Advantage: Often eligible for HSA/FSA purchase, lowering out‑of‑pocket expenses.

Why Kineon’s Pods Stand Out vs Competitors?

Prungo’s wattage‑heavy pods and Bioflex’s lifestyle‑oriented bundles confuse volume with efficacy, bleeding energy outward or diluting dosing discipline. In contrast, the MOVE+ Pro embodies photobiomodulation science: calibrated dosing, ergonomic targeting, and repeatable outcomes.

Larger bundles like Bioflex 360 or FlexBeam may chase full‑body intensity, but Kineon's MOVE+ PRO LASER excels in portability, safety, and joint‑specific precision, healing at the peak, not suppressing in the trough.

Kineon’s MOVE+ Pro isn’t just about calibrated dosing; its physical design is engineered for real‑world recovery. The modular pods contour naturally around joints, maintaining a consistent angle and distance so light delivery stays uniform even on curved anatomy like knees, shoulders, or hips. Straps hold the modules securely, reducing micro‑motion and ensuring repeatable sessions.

Unlike flat LED wraps that scatter light unevenly, Kineon’s system combines 808 nm medical‑grade lasers with 660 nm LEDs, giving both depth and coverage. 

Thermal management keeps sessions comfortable, while the modular layout adapts to different body areas without wasted energy at the edges. The result is a system that feels ergonomic, intuitive, and clinically precise, designed not just to shine light, but to deliver healing light exactly where it’s needed.

 

The Science of Photobiomodulation: Espresso vs Full Breakfast

Photobiomodulation (PBM) is like feeding your cells light-based nutrition. But just like food, it’s not about how much you pile on the plate;  it’s about what your body can absorb and use.

Back to the two Red Light Therapy Wavelengths and how we associate them in terms of a cup  of Joe;

Red light (620–700 nm) is the espresso shot,  fast, surface-level energy that perks up your skin, ligaments, and shallow tissues.

Near-infrared light (780–1100 nm) is the full breakfast; it's deeper, sustained energy that reaches joints, muscles, and even bone.

Both wavelengths activate cytochrome c oxidase, the enzyme that flips the switch on ATP production. More ATP means more cellular energy, less oxidative stress, and faster recovery. 

“Sip Easy, It’s Brewed to Heal, Not to Burn.”

In contrast, Kineon’s MOVE+ Pro is engineered to remain within the stimulatory peak. Dual wavelengths, 660 nm red for superficial repair and 808nm infrared laser for deep tissue penetration, are delivered at a calibrated 36 J/cm² in 15 minutes, ensuring athermic stimulation aligned with cytochrome c oxidase absorption spectra.

This precision keeps dosing reproducible, avoids thermal suppression, and consistently drives ATP synthesis, oxidative stress modulation, and nitric oxide release.

caption: "Think of red light therapy like coffee: too little does nothing, too much leads to burnout. Photobiomodulation demands precise dosing, not just flashy power, as shown by the Arndt-Schulz biphasic curve. The Kineon MOVE+Pro hits the therapeutic sweet spot, backed by 6K+ medical studies and multiple awards. The icons represent your mitochondria: from no effect to optimal response with MOVE+Pro, versus overstimulation from excessive power that misapplies the Bunsen-Roscoe principle."

But here’s the catch

Just like your body can’t absorb 10 espresso shots at once, your cells can’t process unlimited light. The biphasic dose-response curve shows that too little light has no effect, and too much can actually suppress healing.

Backed by Science and Endorsements

Endorsed by Olympic athletes and trusted by physiotherapists, the MOVE+ Pro translates clinical science into everyday recovery, delivering calibrated precision that competitors like PRUNGO Flux Go cannot match.

More power may sound impressive, but without dosing accuracy, it overshoots the therapeutic window. Kineon wins because it respects science and is engineered for bio-effective regeneration and reparative power instead.

PRUNGO highlights anecdotal user feedback, but lacks published studies or accredited endorsements. In contrast, Kineon MOVE+ Pro is recognized by athletes, physiotherapists, and clinicians, reinforced by coverage in leading publications and peer‑reviewed papers, and awarded with the prestigious Clinicians' Choice Awards.

The Kineon MOVE+ Pro with laser therapy is backed by a wealth of professional and medical endorsements, while a thorough search reveals little comparable validation for Prungo. This blend of clinical expertise and lived user experience makes the MOVE+ Pro authentically trustworthy, a device that bridges rigorous science with real‑world recovery.

 

Athlete Endorsements

Pro‑grade athletes swear by this dosing precision; here are their stories of conquering training setbacks and injuries with consistent use and correct technique.

Ben Greenfield, the opening speaker above, is also a renowned authority in the fitness and recovery niche. (biohacker, physiologist, bestselling author).

“This red‑light therapy device from Kineon is a complete GAME CHANGER. In just a few short days, you could be on your way to living with a lot less pain.”  Ben Greenfield, biohacker, physiologist, and bestselling author.

Finding the Right Dose for Pain Relief

The Science Behind Kineon MOVE+ Pro

As Forrest Smith, founder of Kineon, explains, the MOVE+ Pro was designed around the biphasic dose‑response curve, not raw output. That’s why it delivers 36 J/cm² in 15 minutes, enough to activate healing without tipping into inhibition.

PRUNGO FluxGo’s Overdose Problem

In contrast, PRUNGO FluxGo pushes 200+ J/cm², flooding superficial tissues and tipping into the inhibitory zone. More wattage may look impressive in marketing videos, but it risks suppressing cellular repair instead of accelerating it.

When Kineon says “more isn’t better,” it’s not caution; it’s science.

From Lab to Real‑World Recovery

Kineon MOVE+ Pro bridges clinical dosing precision with everyday usability. Backed by physiotherapists, athletes, and peer‑reviewed science, it delivers laser‑calibrated therapy that respects the therapeutic window. 

Red light therapy isn’t about wattage wars; it’s about respecting biology. The Arndt‑Schulz curve shows that healing happens only within a precise therapeutic window. That’s why Kineon MOVE+ Pro delivers calibrated 36 J/cm² in 15 minutes, engineered for regeneration and repair, while PRUNGO FluxGo overshoots with 200+ J/cm², risking suppression instead of recovery.

Beyond Power: Precision Dosing Unlocks Mitochondrial Repair

Why Kineon’s got it right?

Here’s the fun part: there are two flavors of light at play, each with its own vibe.

Red light (620–700 nm): This one hangs out on the surface. It’s what you see in beauty masks, red light blankets, or saunas. It talks directly to your skin cells, ligaments, and shallow tissues. 

The mitochondria (your cells’ powerhouses) soak it up, kickstart ATP production, and suddenly you’ve got better blood flow, calmer inflammation, and skin that looks like it just had a spa day.

Near‑infrared light (780–1100 nm) is the deeper diver. It moves past the surface to reach muscles, joints, and even bone tissue, supporting natural energy processes at a cellular level. The same “mitochondria magic” now works in the places where you want to feel more ease and flexibility. That’s why wellness enthusiasts, athletes, and everyday users celebrate near‑infrared therapy; it helps them stay active, feel energized, and enjoy movement with confidence.

At the cellular level, both wavelengths wake up cytochrome c oxidase,  the enzyme that flips the switch on ATP (adenosine triphosphate). More ATP = more energy for repair, less stress inside the cell, and faster bounce‑back.

So, red light isn’t just “skin‑deep.” It’s like your mitochondria’s morning espresso shot. Near‑infrared? That’s the full breakfast, deeper, longer‑lasting energy that helps you move without aches.

“Beyond Reciprocity: The Real Rules of Light Therapy.”

In low‑level light therapy, the Arndt‑Schulz biphasic curve defines the therapeutic window: sub‑threshold fluence yields negligible effect, optimal dosing stimulates mitochondrial repair, and supra‑threshold exposure suppresses function.

This nonlinear reality directly contradicts the Bunsen‑Roscoe reciprocity rule, which assumes energy density alone dictates outcomes. Devices modeled on reciprocity, such as PRUNGO’s intensity‑driven arrays, risk overshooting into inhibition, mistaking power for efficacy.

Reciprocity Vs PhotoBiomodulation: The Right Way!

From the Bunsen‑Roscoe reciprocity plot and a recreation below, of the Prungo Plot, this illustrates a simple inverse relationship between irradiance and exposure time, assuming that equal energy density produces equal biological effect. Prungo’s “power‑is‑impact” stance mirrors this reciprocity model, presenting higher irradiance over shorter durations as inherently superior. 

However, this equivalence does not hold in living tissues. Photobiomodulation follows the Arndt‑Schulz biphasic dose‑response, where cellular outcomes depend on remaining within a defined therapeutic window. Thus, while the Prungo plot and the reciprocity curve share an identical shape and message, they both oversimplify biological complexity and risk suppressing rather than stimulating tissue repair.

Graph 1: Arndt‑Schulz Biphasic Dose Response Curve (The science baseline).

Split panel with the Bunsen-Roscoe principle for comparison

Graph 1: Arndt-Schulz Biphasic Dose Response Curve

This graph looks identical to the graph in Prungo's similar article; you can see how the Arndt-Schulz biphasic curve differs greatly from this principle, not only in mechanism but in the shape of the graph.

Prungo’s curve perfectly illustrates the Bunsen-Roscoe Principle: equal energy density yields equal effect, regardless of whether delivered rapidly or gradually. Its identical shape reinforces the law of reciprocity, on which it is based. 

Why Healing Tissues Don’t Obey the Bunsen-Roscoe Principle?

"Equal energy density (J/cm²) produces equal biological effect, regardless of whether delivered quickly at high intensity or slowly at low intensity."

Healing tissues are more like a garden than a test tube. The Bunsen-Roscoe Principle assumes that equal energy always produces equal effect, the way a chemical solution responds predictably to light. But living tissues, like plants, thrive only under measured sunlight.

A gentle, steady dose nurtures growth, while too much light scorches and stunts it. That’s why healing biology follows the Arndt-Schulz biphasic curve instead of strict reciprocity: in living systems, timing and moderation matter as much as the total dose.

"Same Dose, Different Impact: According to the Bunsen-Roscoe Principle, equal energy density can be delivered over varying durations. Prungo delivers a rapid, intense dose; Kineon MOVE+ opts for a slower, sustained release, both reaching the same total energy, but with vastly different biological implications."

"Precision Over Power: While the Bunsen-Roscoe Principle shows that equal energy density can be delivered over time, the Arndt-Schulz Curve reveals that only moderate doses yield optimal biological effects. Kineon MOVE+ stays in the therapeutic sweet spot, Prungo overshoots into the inhibitory zone."

 

What’s Wrong with Reciprocity?

The traditional Bunsen‑Roscoe plot assumes that equal energy density yields equal biological effect, regardless of whether it comes from high irradiance over a short time or low irradiance over a long time. Prungo’s blog echoes this reciprocity mindset by showcasing their higher‑power arrays as proof of efficacy, essentially arguing that more wattage in less time equals better outcomes.

But this is the same oversimplification the Arndt‑Schulz curve powerfully disproves: living tissues don’t respond linearly to energy totals. Just as the Bunsen‑Roscoe principle flattens biology into chemistry, Prungo’s “power stance” confuses brightness with benefit, risking suppression instead of stimulation.

Reciprocity vs Precision

PRUNGO’s dosing philosophy aligns with the Bunsen‑Roscoe reciprocity principle, the idea that energy density alone determines biological effect.

In photobiomodulation, the critical photoacceptor is cytochrome c oxidase, the terminal enzyme of the mitochondrial electron transport chain.

Its absorption spectra are highly specific: red light in the 660 nm range stimulates superficial tissues, while near‑infrared wavelengths around 808 nm penetrate deeper structures and activate cytochromes within muscle, tendon, and joint tissue. The response is not linear.

According to the Arndt‑Schulz biphasic law, weak stimuli initiate repair, moderate doses reach a peak of mitochondrial activation, and excessive exposure suppresses enzymatic activity, reducing ATP synthesis and impairing recovery.

This is where PRUNGO’s reciprocity model fails. By pushing 216 J/cm² under the assumption that “more power equals more benefit,” it ignores the nonlinear nature of cytochrome receptivity. 

A short, high‑intensity blast does not equal a longer, lower‑intensity exposure. Instead, it risks driving cytochromes into the suppression zone, inhibiting the very repair processes photobiomodulation is meant to stimulate.

Kineon’s MOVE+ Pro is engineered to respect this biology. Its dual wavelengths, 660 nm LEDs for surface repair and 808 nm medical‑grade lasers for deep tissue penetration, are calibrated to deliver ~36 J/cm² in 15 minutes, squarely within the stimulatory peak of the biphasic curve. 

Coherent laser beams ensure precise penetration, while LEDs provide broad superficial activation, together maximizing cytochrome engagement without overshoot.

Image above: This comparative illustration highlights the difference between laser and LED light delivery in therapeutic applications. On the left, a coherent laser beam concentrates energy into a narrow region, resulting in localized heat and pressure. Adapted from Kineon: A visual comparison of laser vs LED beam coherence and power distribution in photobiomodulation therapy.

The mechanism of action is therefore both targeted and cumulative: increased ATP production, modulation of oxidative stress, and nitric oxide release, all achieved within the therapeutic window. This precision, backed by over 6,000 clinical papers and 15,000 hours of testing, explains why the MOVE+ Pro is trusted by athletes, clinicians, and tens of thousands of users worldwide.

Graph: Dose to Response Model in Photobiomodulation Therapy

The Bunsen-Roscoe Reciprocity Principle illustrates a linear relationship where biological effect is assumed to depend solely on total energy density (J/cm²), regardless of the combination of irradiance (mW/cm²) and exposure time (s). 

This model suggests that a brief, high-intensity exposure is equivalent to a longer, low-intensity exposure if the total energy delivered is the same.

The Arndt–Schulz Law depicts a biphasic, nonlinear response curve. Biological activity increases with dose up to an optimal healing zone, beyond which further stimulation leads to suppression. This model emphasizes the importance of calibrated dosing, where both irradiance and exposure time must be carefully controlled to remain within the therapeutic window and avoid inhibitory effects.

Red light therapy works by stimulating blood flow and boosting cellular energy (ATP), reducing pain and inflammation while accelerating tissue repair.

The MOVE+ Pro is engineered around the Arndt‑Schulz Biphasic Dose Curve, the principle that too little light has no effect, the right dose heals, and too much can inhibit recovery. Its three preset modes target the gold‑standard wavelengths of 660nm and 808nm, delivering a calibrated 36 J/cm² in 15 minutes, squarely within the healing zone.

The distinction between LEDs and lasers isn’t just technical; it’s physiological. As Kineon’s research explains, LEDs scatter light broadly, while lasers deliver coherent beams that penetrate deep tissue with precision. This is why the MOVE+ Pro combines both: LEDs at 660 nm for surface repair, and medical‑grade 808nm and 850nm lasers for targeted recovery. 

Built on over 15,000 hours of research and testing, and backed by more than 6,000 clinical papers, the MOVE+ Pro is engineered to stay within the optimal therapeutic window defined by the Arndt‑Schulz biphasic dose curve.

In practice, that means a calibrated 36 J/cm² dose that maximizes healing without overshoot, a level of precision trusted by athletes, clinicians, and over 35,000 users worldwide.

 

The strength of the MOVE+ Pro lies in its precision engineering around the Arndt‑Schulz biphasic dose curve. By delivering a calibrated 36 J/cm² through dual wavelengths, 660 nm LEDs for surface tissue repair and 808 nm medical‑grade lasers for deep penetration, it ensures stimulation remains within the therapeutic window. 

This dosing discipline transforms photobiomodulation into a reproducible therapy that's consistent, safe, and clinically effective. For athletes, clinicians, and everyday users, that precision means recovery you can trust, not just faster, but biologically optimized.

 

The Illusion of Power: Why PRUNGO’s Graph Misleads?

Not all red lights are created equal. Kineon MOVE+ Pro is engineered around biology, dual wavelengths (660 nm LEDs for surface repair, 808/850 nm lasers for deep tissue), and a calibrated 36 J/cm² dose that stays inside the Arndt‑Schulz healing zone. It’s precision by design.

PRUNGO, by contrast, makes bold claims about its red and near‑infrared therapy, but the science behind those claims remains vague. It references therapeutic wavelengths, yet omits exact specifications, most notably the gold‑standard 808 nm laser, known for deep tissue recovery. 

And while it uses the word “LASER,” PRUNGO relies primarily on focused LEDs, which scatter light and lack the coherence and penetration of true medical‑grade diodes.

Their page introduces something called Polarized Laser Therapy (PLT)

Stating that polarization enhances tissue penetration, but without clarity on wavelength, dose, or coherence, these claims remain theoretical. PRUNGO’s combination of 3R‑grade lasers, polarized filters, and concentrated LED arrays may look powerful, but it risks overshooting the therapeutic window.

Caption: The Dose Makes the Difference: Total Energy Delivered at Depth

PRUNGO highlights a peak delivery of 28.1 joules over 10 seconds, a number that sounds impressive but lacks biological context. What it really shows is a power spike, not a calibrated therapeutic dose. Missing entirely is how energy is absorbed across tissue layers, especially in the first and second layers, where scattering and attenuation reduce effectiveness.

This kind of graph promotes intensity as a proxy for healing, a classic reciprocity mindset. But photobiomodulation isn’t about dumping energy into tissue. It’s about delivering the right dose, at the right wavelength, with the right timing. Where PRUNGO gambles on spectacle, Kineon respects the biphasic dose curve. That difference matters: calibrated dosing supports recovery, while vague intensity risks suppression. However, many have used it with personal success stories; it varies vastly across individuals.

PRUNGO’s graph highlights a massive 216 J/cm² dose over 20 minutes, nearly six times the energy of Kineon’s 36 J/cm². But this isn’t a win. It’s a red flag.

Graph 2: Overlay or side‑by‑side comparison: Kineon plotted at 36 J/cm² in the healing zone, PRUNGO plotted >200 J/cm² beyond the peak.

Credits: Data adapted from PRUNGO FluxGo’s published dose‑depth chart. Source: PRUNGO official website (accessed December 3, 2025). This graph is an independent recreation for educational and comparative purposes. No endorsement by PRUNGO is implied.

Think of recovery like watering a plant. A measured amount of water helps it grow, but dumping six times more doesn’t make it grow faster;  it drowns the roots. PRUNGO’s “more is better” approach is like flooding the plant, while Kineon’s calibrated dose is like giving it exactly the right amount to thrive.

 

With a power output of 216 J/cm², PRUNGO’s dosing ignores the therapeutic principles of the Arndt-Schulz biphasic dose-response curve, risking overstimulation rather than calibrated healing, which may impede it.

Kineon vs Prungo: Why More Power Isn’t Always Better in Red Light Therapy

When it comes to red light therapy or infrared therapy, more power doesn’t always mean better results; we know that now, but it deserves more of a focused beam on specs and the numbers.

Kineon’s MOVE+ Pro and Prungo’s Flux Go both promise deep-tissue relief, but they take different paths to get there. From wavelength to technical specs, there’s a world of differences in how it induces Photobiomodulation, or how close to the therapeutic bandwidth it achieves its objective.

While Prungo delivers higher dose intensity, Kineon focuses on clinical precision, ergonomic design, and consistent delivery. This guide compares both devices across wavelength, dose, modularity, and real-world comfort, helping you choose the one that fits your recovery goals.

Kineon vs Prungo: Spec Wars vs Healing Truths: How Kineon and Prungo Really Compare.

Now that we’ve explored how red light therapy works, let’s compare Kineon’s MOVE+ Pro and Prungo’s Flux Go across the specs that matter, from wavelength and dose delivery to modular design and real-world usability. Because healing isn’t just about numbers. It’s about what fits your body, your goals, and your life.

Wavelengths: Exact vs Approximate

PRUNGO correctly identifies the clinically active ranges,  630‑680 nm red for superficial repair and 810‑850 nm near‑infrared for deeper tissues. These are well‑established in photobiomodulation research.

Kineon’s distinction lies in specifying 660 nm LEDs (surface) and 808 nm laser diodes (depth). While PRUNGO references ranges broadly, Kineon delivers exact, clinically validated wavelengths with transparent specs.

Technology (LED vs Laser):

PRUNGO emphasizes polarized filters to reduce scatter, but its reliance on LEDs limits coherence and precision. Even with polarization, LEDs cannot match the penetration of true laser diodes.

Kineon’s advantage is the use of medical‑grade 808 nm laser diodes, which produce coherent beams that reach several centimeters into tissue, a pivotal difference for musculoskeletal recovery.

Dose Discipline:  Calibrated vs Overshoot into oblivion!

PRUNGO’s claim of “greater power for deeper penetration” aligns with the idea that higher irradiance can speed dosage accumulation, relying on the Bunson-Roscoe principle of irradiation, we know that cells don’t respond this way. 

However, its 216 J/cm² output risks overshooting the therapeutic window, potentially inhibiting cellular repair, with respect to the graph provided on their comparative review. We’ve addressed this above in the context of the Arndt-Schulz Biphasic response curve. 

Ergonomics & Design Integrity

The website, layout, and overall format, even down to the tone of the content, feel heavily borrowed from Kineon, amounting to near mimicry rather than original design. This extends beyond branding into the product itself: PRUNGO adopts the same pod‑based concept with adjustable straps, storage, and charging provisions that closely resemble the MOVE+ Pro system.

It even pairs red and near‑infrared wavelengths in an attempt to match Kineon’s specifications. But here’s the critical difference: PRUNGO relies on LEDs and polarized filters, not true medical‑grade lasers.

Without coherent beams, it cannot achieve the deep‑tissue penetration and calibrated dosing that define Kineon’s clinical precision. In short, PRUNGO imitates the look and feel, but falls short in delivering the science‑backed performance that sets Kineon apart. 

Kineon vs BioFlex Nano: Recovery Specialist vs Wellness Generalist

Kineon’s Advantage: Precision Over Spectacle

Kineon MOVE+ Pro is engineered for clinical recovery, calibrated to deliver 36 J/cm² in 15 minutes, right inside the Arndt‑Schulz therapeutic window. Its dual‑wavelength system combines 808 nm medical‑grade lasers for deep tissue penetration with 660 nm LEDs for surface repair, ensuring synergy that activates healing rather than risking inhibition. This precision has earned Kineon recognition, such as the Clinician's Choice Award, and trust from physiotherapists, Olympic athletes, and clinicians worldwide. It’s not about how bright it looks; it’s about how well it heals.

BioFlex Nano: Lifestyle Companion, Not Clinical Recovery

BioFlex Nano positions itself as a portable wellness pod, easy to travel with, that is marketed for circulation, skin health, and general vitality. Using 660 nm and 850 nm LEDs, it offers broad coverage but lacks the medical‑grade laser precision and calibrated dosing protocols that define Kineon. Its output is more about glow than grind, which is appealing for lifestyle use but not optimized for deep joint repair or musculoskeletal recovery.

Verdict

Kineon MOVE+ Pro: the recovery specialist, engineered for joint healing and deep tissue repair.
PRUNGO FluxGo: the power‑hungry wildcard, flashy in intensity but imprecise in delivery.
BioFlex Nano: the wellness generalist, good for circulation and skin tone, but not a clinical recovery tool.

Kineon vs Its Competitors: What Sets Them Apart & Why Does It Matter?

Kineon  MOVE+Pro: Your Recovery Specialist (pictured above)

Prungo:  Power-hungry generalist. (product photos available on Prungo website)

Bioflexwave & Nano: Lifestyle companion.(photos available on BioFlex nano and 360 bundle BioFlex Website)

Tech Spec Showdown: Precision vs Power in Red Light Therapy

Let's break it down on the grounds of Technical Specs and how they really fare against each other. 

Now that we’ve unpacked how red light therapy works at the cellular level, let’s see how those principles translate into real‑world device design. Healing isn’t just about numbers on a spec sheet; it’s about how a device aligns with your body, your recovery goals, and your lifestyle.

This is where philosophies diverge

•Kineon MOVE+ Pro is built on precision. It uses medical‑grade 808 nm lasers paired with 660 nm LEDs to deliver energy like a guided arrow, stratified, layered, and clinically validated to reach the tissues that need repair. Its modular pods and ergonomic design make it ideal for targeted recovery of joints such as knees, elbows, and shoulders.

• PRUNGO FluxGo leans on raw output. It's 650 nm + 850 nm LEDs with polarized lenses that scatter energy broadly. Marketed as “laser‑like,” it’s closer to a floodlight on a football field, bright, wide, but far less targeted. While it boasts high irradiance, the lack of true medical‑grade lasers raises questions about dosing precision and long‑term efficacy.

• BioFlex Nano Pod takes the portable lifestyle route. Compact and handheld, it uses 660 nm + 850 nm LEDs with a total output of ~3 W across 19 diodes. At just 45 mm in diameter, it’s lightweight and designed for circulation, skin health, and everyday relief. However, its lower power and absence of laser precision make it more of a wellness gadget than a clinical recovery tool.

•BioFlex 360 Bundle represents the scalable coverage model. By combining multiple Nano Pods into a synchronized strap‑based system, it enables broader treatment areas such as the back or full limb coverage. While this design offers adaptability and convenience, it still relies solely on LED output without laser precision, meaning dosing accuracy and depth of penetration remain limited compared to Kineon’s stratified laser‑LED approach.

Caption: How does the MOVE+ PRO stack up? A side-by-side comparison of wearable red light therapy versus panels, lasers, and beds, highlighting cost, portability, dosing precision, and joint pain effectiveness.

Spec Wars vs Healing Truths: Kineon vs PRUNGO & BioFlex Systems

The healing truth in photobiomodulation (PBM) is simple: more power is not always better. Devices like the Kineon MOVE+ Pro, PRUNGO FluxGo, and BioFlex Nano/360 systems embody very different philosophies, one built on precision, one on spectacle, and one on portability and scalability.

Light Source Integrity

•Kineon MOVE+ Pro: Combines LEDs with medical‑grade 808 nm lasers, producing coherent beams that penetrate predictably into tissue.
•PRUNGO FluxGo: Relies on high‑output LEDs with polarized lenses. Bright, but scatter reduces precision and depth.
•BioFlex Nano/360: LED‑only systems. Lightweight and adaptable, but limited penetration and dosing accuracy compared to lasers.

 

Wavelength Strategy

•Kineon MOVE+Pro Class 1 LASER: Dual‑layered approach, of 660 nm LEDs for surface repair, 808 nm lasers for deep tissue recovery.
•PRUNGO: Uses ~650 nm and ~850 nm LEDs. Effective for penetration but lacks laser precision, more of a floodlight than a guided arrow.
•BioFlex nano and 360 bundles: 660 nm + 850 nm LEDs, suitable for circulation and skin health, but not optimized for musculoskeletal recovery.

 

Dose Discipline

•MOVE+Pro Class 1 LASER By Kineon Labs: Calibrated ~36 J/cm² in 15 minutes, aligned with the Arndt‑Schulz biphasic dose‑response curve.
•PRUNGO: Exceeds 200 J/cm² in 20 minutes, risking inhibition rather than stimulation.
•BioFlex Nano & 360 Bundle: Variable, uncalibrated dosing, safe for wellness routines but not clinically structured for recovery.

 

Usability & Ergonomics

•MOVE+ Pro Class 1 LASER: Ergonomic pods strap securely to joints, ensuring consistent contact and dosing.
•PRUNGO: Strap system is cumbersome, prone to shifting, and modules can desync.
•BioFlex Nano/360: Extremely lightweight and portable, but adhesive patches/straps prioritize convenience over precision fit.

 

Clinical Backing

•MOVE+ Pro Class 1 LASER: Anchored in published research on 808 nm lasers, validated for joint recovery and pain relief.
•PRUNGO: Operates within studied ranges but emphasizes intensity over dosing discipline, leaning on marketing claims.
•BioFlex Nano & 360 Bundle: Positions itself as a wellness companion, with less emphasis on clinical validation and more on lifestyle appeal.

 

Treatment Modes

•MOVE+Pro Class 1 LASER: One calibrated mode, always within the therapeutic window.
•PRUNGO: Three selectable modes (Mild, Mid, Strong), leaving dosing decisions to the user without guidance.
•BioFlex Nano & 360 Bundle: Straightforward LED output, but without structured dosing protocols.

 

The Core Difference

•Kineon MOVE+ Pro Class 1 LASER: Built for precision, dual wavelengths, medical‑grade lasers, ergonomic design, and clinically validated dosing.
•PRUNGO FluxGo: Built for power, high‑output LEDs, multiple modes, flashy specs that scatter energy and overshoot the therapeutic window.
•BioFlex Nano/360: Built for portability and scalability, lifestyle devices that support circulation and skin health, but lacking the depth and dosing discipline needed for serious recovery.

Photobiomodulation vs High Irradiance: Which Delivers Real Recovery?

Recovery outcomes in light therapy hinge on one principle: staying inside the therapeutic window. Within this range, cells are stimulated to repair and regenerate; outside it, the benefits diminish or even reverse. Devices designed around calibrated dosing, like the Kineon MOVE+ Pro, keep energy delivery aligned with clinical protocols. High‑irradiance systems, such as PRUNGO FluxGo, often overshoot this window, creating risks that compromise healing rather than enhance it.

Risks of High‑Power Devices

The biphasic dose‑response curve makes clear that light therapy is a balancing act: too little light has no measurable effect, while too much can actively inhibit healing. When devices deliver energy beyond the therapeutic window, several risks emerge. Excessive irradiance can push cells into overdrive, triggering the overproduction of reactive oxygen species (ROS). Instead of repairing tissue, these unstable molecules damage DNA, proteins, and cell structures, undermining recovery.

There is also the danger of tissue overheating. Concentrated light held too close for too long can cause redness, swelling, or even burns and blistering, turning a therapy session into a source of injury. The eyes are particularly vulnerable; direct exposure to intense red or near‑infrared light without proper protection can irritate or, in severe cases, damage the retina.

Even when overt damage does not occur, users sometimes experience temporary symptom flare‑ups. Pain or tingling may increase briefly as tissues adjust to heightened cellular activity. In other cases, the boost in circulation and lymphatic activity produces detox‑like effects such as mild headaches, fatigue, or nausea, symptoms that usually ease with hydration and rest.

These risks underscore the importance of precautions. Safe practice means respecting manufacturer guidelines for treatment times and distances, avoiding sensitive areas such as the thyroid, eyes, or cancerous lesions, and consulting a medical professional if pregnant, photosensitive, or taking medications that heighten light sensitivity. Above all, the principle of “start low and slow” applies: shorter, lower‑intensity sessions allow the body to adapt gradually, reducing the chance of overdosing and ensuring that photobiomodulation remains a supportive, not disruptive, therapy.

Caption: Kineon MOVE+ Pro safety guide: Understanding the risks of overdosing with high-irradiance photobiomodulation and how to practice safe, effective red light therapy.

Clinical Scenarios Where Precision Matters

Photobiomodulation (PBM) therapy has demonstrated promise across a wide spectrum of medical conditions. By activating cytochrome c oxidase in the mitochondrial respiratory chain, PBM enhances ATP synthesis and cellular resilience.

Light‑sensitive ion channels further trigger calcium influx, transcription factor activation, and gene expression cascades that orchestrate anti‑inflammatory, anti‑oxidant, and anti‑apoptotic responses.

Neurological Disorders

Evidence supports PBM’s role in stroke recovery, dementia, Parkinson’s disease, brain trauma, and depression. These cascades foster neurogenesis and synaptogenesis, helping restore neural function and protect against degeneration. Even in healthy individuals, PBM has been linked to improved cognitive performance.

You've seen our schematic adaptation of the Principles of Photobiomodulation PBM above, but this is where it finds its greatest application.

Gut Microbiome Modulation & a thinner waistline sans the bloating

Emerging studies suggest that Photobiomodulation (PBM may also influence gut health. By regulating transcription factors such as NF‑κB and AP‑1, PBM reduces local inflammation, strengthens epithelial barrier integrity, and creates conditions favorable for beneficial microbial populations. This frontier highlights PBM’s systemic potential beyond musculoskeletal and neural tissue degenerative processes.

Together, these applications highlight the versatile applications of Photobiomodulation in diseases far beyond what we traditionally treat, and it is a flourishing science as an alternative or supplement to your pharmacy prescription.

Precision dosing ensures stimulation without suppression, aligning with the Arndt‑Schulz curve. This principle matters across orthopedic, neurological, and athletic contexts:

Knee & Hip Replacement Recovery

After joint replacement surgery, inflammation and tissue stress can slow rehabilitation. Calibrated dosing with photobiomodulation reduces inflammatory markers while stimulating mitochondrial activity, helping tissues repair more efficiently. By staying within the therapeutic window, patients often experience less swelling and faster gains in mobility, shortening overall recovery timelines.

Muscle Recovery & Strain Rehabilitation

Athletes and active individuals benefit from precision dosing because it accelerates muscle fiber repair without overwhelming cells. Controlled energy delivery enhances circulation, reduces micro‑tears, and supports protein synthesis. Unlike high‑irradiance devices that risk suppression, calibrated PBM keeps recovery predictable, allowing athletes to return to training sooner with reduced risk of reinjury.

Rotator Cuff & Meniscus Surgery

Post‑surgical tissues are delicate and highly responsive to dosing accuracy. Targeted PBM energy delivery reduces downtime by stimulating collagen production and modulating inflammation exactly where repair is needed. Precision dosing ensures that healing is supported rather than disrupted, making rehabilitation smoother and more consistent for patients recovering from orthopedic procedures.

Stroke Recovery

Emerging research highlights PBM’s role in enhancing neuroplasticity, the brain’s ability to reorganize and form new connections. Disciplined dosing is critical here, as neural tissue is particularly sensitive to overstimulation. By delivering light energy within the therapeutic window, PBM supports synaptic repair and functional recovery, offering promise in rehabilitation strategies for stroke patients.

The Verdict: Precision, Power, or Lifestyle?

When the dust settles on the technical comparisons, what emerges is less a battle of specifications and more a clash of philosophies. Each device represents a distinct approach to photobiomodulation, and understanding those differences is key to choosing the right tool for recovery.

Kineon MOVE+ Pro stands out as the recovery specialist. Its design is anchored in clinical science: dual wavelengths (660 nm LEDs for surface repair and 808 nm medical‑grade lasers for deep tissue penetration), modular pods that adapt to different joints, and dosing protocols calibrated to the Arndt‑Schulz curve.

This combination ensures that energy is delivered precisely where it is needed, stimulating repair without tipping into suppression. For athletes, post‑surgical patients, or anyone managing chronic pain, the MOVE+ Pro offers predictable, clinically validated outcomes that align with the science of recovery.

PRUNGO FluxGo, by contrast, embodies the philosophy of raw power. Its high‑output LEDs with polarized lenses scatter energy broadly, creating impressive irradiance numbers but sacrificing precision.

While this floodlight approach may appeal to users seeking full‑body coverage, it risks overdosing tissues and pushing them outside the therapeutic window. The multiple modes (Mild, Mid, Strong) add flexibility but leave dosing decisions in the hands of the user, introducing uncertainty. PRUNGO’s strength lies in spectacle, but its weakness is the lack of disciplined dosing that clinical recovery demands.

BioFlex Nano and 360 systems occupy a different niche altogether: lifestyle wellness. Compact, portable, and affordable, they are designed for circulation, skin health, and everyday relief. The Nano Pod’s LED‑only design makes it lightweight and convenient, while the 360 system scales that portability into broader coverage.

 Yet both remain limited by the absence of laser precision and structured dosing protocols. They serve well as wellness companions but fall short when the goal is targeted musculoskeletal or neurological recovery.

Red light therapy devices fall into three broad categories: lifestyle convenience, raw power, and clinical precision. The evidence consistently favors precision, calibrated dosing that stimulates repair without tipping into suppression.

This is where Kineon MOVE+ Pro distinguishes itself. With dual wavelengths, medical‑grade lasers, and modular ergonomics, it delivers targeted energy within the Arndt‑Schulz therapeutic window, ensuring safe, effective recovery every time. Unlike power‑hungry devices that risk inefficiency or inhibition, Kineon’s disciplined approach makes it the leading choice for anyone serious about healing, mobility, and long‑term performance.

Lifestyle devices like BioFlex Nano provide accessibility but lack the rigor needed for serious recovery. The choice, then, is not about which device is “stronger,” but which philosophy aligns with your recovery needs. For those seeking predictable, clinically validated healing, precision remains the smarter path.

Thermal imaging panels labeled “Before” and “After” show how LED-based therapy, as used in the Kineon MOVE+ Pro, achieves more even heat and pressure distribution post-treatment, supporting comfort, safety, and consistent recovery outcomes.

Image: Adapted from Kineon MOVE+PRO in partnership with Kineon MOVE+PRO

Unlike traditional laser devices that concentrate energy into a single point, the Kineon MOVE+ Pro uses a hybrid approach, combining medical-grade lasers with distributed LED coverage. This ensures deep tissue penetration where needed, while maintaining uniform energy delivery across the joint. The result: targeted stimulation without overheating, and consistent recovery across the entire treatment area.

Ready to recover smarter? Shop Kineon MOVE+ Pro today and experience precision therapy that power alone can’t deliver.

References:

1. Arndt-Schulz Biphasic Dose Response Curve: 

• Creator: James D. Carroll, THOR Photomedicine Ltd

• Title: THOR 3D PBM hypothetical dose model and Traditional PBM dose model

• Date: 12 February 2008 (study); image © 2025 THOR Photomedicine Ltd

• Source: http://blog.thorlaser.com/3D

• License: CC BY-SA 4.0 (https://creativecommons.org/licenses/by-sa/4.0/)

• Changes: e.g., “Caption added; minor cropping.”

2. PRUNGO. FluxGo Dose‑Depth Comparison. PRUNGO Official Website. Accessed December 3, 2025. 

3.Reference:https://kineon.io/pages/red-light-therapy-science

Peer-Reviewed Literature

1. Hamblin, M. R. (2016). Mechanisms of photobiomodulation. Journal of Biophotonics.

2. Hamblin, M. R. (2017). Mechanisms of photobiomodulation in cells and tissues. Photochemistry and Photobiology.

3. Chung, H., Dai, T., Sharma, S. K., Huang, Y. Y., Carroll, J. D., & Hamblin, M. R. (2012). The nuts and bolts of low-level laser therapy. Annals of Biomedical Engineering, 40(2), 516–533.

4. Bjordal, J. M., Johnson, M. I., Iversen, V., Aimbire, F., & Lopes-Martins, R. Á. B. (2006). Low-level laser therapy in musculoskeletal pain: A systematic review. Photomedicine and Laser Surgery, 24(2), 158–168.

5. Arndt-Schulz Law of Photobiomodulation. Biphasic dose-response curve in PBM therapy.

6. Springer. (2022). Biphasic dose-response. Lasers in Medical Science. https://link.springer.com/article/10.1007/s10103-022-03664-3

7. SPIE Digital Library. Biphasic Dose Response. In Low-Level Light Therapy: Photobiomodulation. https://www.spiedigitallibrary.org/ebooks/TT/Low-Level-Light-Therapy-Photobiomodulation/6/Biphasic-Dose-Response/10.1117/3.2295638.ch6

8. Nairuz T, Sangwoo-Cho, Lee J-H. Photobiomodulation Therapy on the Brain: Pioneering an Innovative Approach to Revolutionize Cognitive Dynamics. Cells. 2024; 13(11):966. https://doi.org/10.3390/cells13110966

Clinical Trials and Research Registries

1. Kineon. Clinical trial registry (ongoing studies in joint recovery).

Brand and Product Pages

2. Prungo. Red Light Therapy Module – FluxGo. https://prungo.com/products/prungo-red-light-therapy-module-fluxgo

3. BioFlexWave. Wave Nano Pod. https://bioflexwave.com/products/wave-nano-pod

4. BioFlexWave. Science Overview. https://bioflexwave.com/pages/science

Brand Blogs and Educational Content

5. Kineon. How It Works. https://kineon.io/pages/how-it-works

6. Prungo. Kineon vs Prungo Red Light Therapy.

a. https://prungo.com/blogs/buyers-guides/kineon-vs-prungo-red-light-therapy

b. https://prungo.com/nl/blogs/buyers-guides/kineon-vs-prungo-red-light-therapy

7. Kineon Research Blogs:

a. Red Light Wavelengths. https://kineon.io/blogs/news/red-light-wavelengths

b. Dosing in Light Therapy. https://kineon.io/blogs/news/dosing-in-light-therapy

c. Comprehensive Guide to Photobiomodulation. https://kineon.io/blogs/news/a-comprehensive-guide-to-photobiomodulation

d. LED vs Laser Therapy. https://kineon.io/blogs/news/led-light-therapy-vs-laser